Skip to content
Recall Observatory FDA recall evidence

Drug product

Difluprednate Ophthalmic Emulsion 0.05%, For Ophthalmic Use Only, Sterile, 5 mL bottles, Manufactured by Cipla Ltd., India, Manufactured for: Cipla USA, Inc., NJ 07059, NDC 69097-341-35.

D-1328-2022

August 02, 2022

Class II

Product summary

Firm
CIPLA
Event
Event 90702
Status
Terminated
Classification
Class II
Quantity
7,992 bottles
Official record key
drug-enforcement:D-1328-2022

Official wording

Reason: Lack of Assurance of Sterility: Complaints received of defective container closure.

Code information: Lot # DEG3LC2, Exp 05/2023

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility